The global peripheral nerve conduit market was valued at approximately USD 140 million in 2023 and is anticipated to reach USD 411.58 million by 2034, representing a compound annual growth rate (CAGR) of 10.3% from 2024 to 2034. This growth is driven by the rising incidence of autoimmune disorders, which are a significant contributor to nerve damage.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5278
In April 2024, neuroClues®, a MedTech company focused on the detection of neurodegenerative diseases, successfully closed a €5 million fundraising round. This latest funding adds to their previous investments of €4.7 million in 2021 and €2.5 million from the European Commission’s EIC Accelerator, bringing their total fundraising to €12 million. Furthermore, the company has been approved for up to €9 million in additional funding from the EIC Fund.
In October 2023, BioCircuit Technologies received a $1.9 million grant from the National Institutes of Health (NIH) to support a $2.4 million project aimed at developing and commercializing Nerve Tape®, the first technology for sutureless repair of transected nerves.
Diabetes is a widespread condition affecting millions globally, with increasing cases attributed to unhealthy diets, sedentary lifestyles, alcohol consumption, and occupational hazards. A serious complication associated with diabetes is diabetic neuropathy, which affects up to 50% of individuals with the disease and primarily manifests in the peripheral nerves.
As with any surgical procedure, nerve graft surgeries carry inherent risks. Potential complications include infection, scarring, and issues with wound healing. Additionally, there is a possibility that patients may not regain their expected level of function post-surgery.
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/peripheral-nerve-conduit-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5278
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Visit Dental Specifics: https://www.towardsdental.com
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Vein Finder Market Growth and Forecast (2024 - 2032) The global vein finder market is projected to expand from USD… Read More
Bone Densitometer Market Overview Growth, Trends and Future Projections The global bone densitometer market was valued at USD 308.33 million… Read More
Global Market for Autoimmune Hepatitis Diagnosis and Treatment Projected Growth and Trends The global market for autoimmune hepatitis diagnosis and… Read More
Hemato-Oncology Testing Market Growth and Key Players The global hemato-oncology testing market was valued at $3.17 billion in 2023 and… Read More
Synovial Sarcoma Treatment Market Insights The synovial sarcoma treatment market was valued at USD 822.74 million in 2023 and is… Read More
Chronic Lower Back Pain Market Growth, Future Trends and Forecast The chronic lower back pain market was valued at $2.46… Read More